by Dr. Clark Hansen, NMD | Jun 7, 2010 | Health Condition, Health Research, Hormones, Medication, Women's Health
Why has the FDA moved so slowly on this issue. Bisphosphonates as a class of drugs should be taken off of the market immediately. Fosamax and femur fractures : FDA is investigating possible links By Mary Rice Tuesday, March 9th, 2010 Original Source:...
by Dr. Clark Hansen, NMD | Feb 2, 2010 | Health Condition, Hormones, Medical Tests, Men's Health, Women's Health
Both men and women produce progesterone throughout their lives. As we age, progesterone levels decrease significantly in both sexes. A woman’s progesterone begins declining at age 35 and a man’s progesterone begins falling at age 45. The decline of...
by Dr. Clark Hansen, NMD | Nov 25, 2009 | Fitness and Health, Health Condition, Hormones, Medical Tests, Women's Health
On November 17, 2009, the U.S. Preventive Services Task Force panel of 14 doctors and scientists recommended that women in their 40s should stop getting routine annual mammograms; women over 50 should cut back to one mammogram every other year and women over age 74...
by Dr. Clark Hansen, NMD | Nov 10, 2009 | Fitness and Health, Food and Nutrition, Health Condition, Hormones, Medication
On January 1, 2009, the New England Journal of Medicine published a report from the FDA, which says that the Osteoporosis drug Fosamax may now be linked to cancer. The FDA received 23 reports of esophageal cancer possibly linked to the drug between its October 1995...
by Dr. Clark Hansen, NMD | Jul 16, 2009 | Fitness and Health, Food and Nutrition, Hormones, Women's Health
Stress seems synonymous with life in the 21st century. Who doesn’t feel rushed, pressured, hurried, anxious, or worried about deadlines, commitments, work, finances, or relationships. Whether from a charging lion, or a pending deadline, the stress response is...
by Dr. Clark Hansen, NMD | Apr 7, 2009 | Fitness and Health, Food and Nutrition, Health Condition, Hormones, Medication, Therapy, Women's Health
A new study published in the February 5, 2009, edition of the New England Journal of Medicine, found that women who take Estrogen-Progestin combination hormone therapy for more than five years suffer a doubling of their risk of getting breast cancer and the risk...
